Evidence map›Paper›PMID 18505475›Full record

ArticleJournal of cellular and molecular medicine2010

Foetal hepatocyte transplantation in a vascularized AV-Loop transplantation model in the rat.

H C Fiegel, G Pryymachuk, S Rath, O Bleiziffer, J P Beier, H Bruns, D Kluth, R Metzger, R E Horch, H Till and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Tissue engineering and regenerative medicine -where do we stand?Journal of cellular and molecular medicine · 2012
    Review
  11. Article
  12. Biomaterials to prevascularize engineered tissues.Journal of cardiovascular translational research · 2011
    Review
  13. Article
  14. Article
  15. Engineering skeletal muscle tissue--new perspectives in vitro and in vivo.Journal of cellular and molecular medicine · 2010
    Review
  16. Review
  17. [The development of plastic surgery: retrospective view of 80 years of "Der Chirurg" (The Surgeon)].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2009
    Article
  18. Translating tissue engineering technology platforms into cancer research.Journal of cellular and molecular medicine · 2009
    Review
  19. Development of hepatic tissue engineering.Pediatric surgery international · 2009
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

H C FiegelDepartment of Pediatric Surgery, University of Leipzig, Germany. henning.fiegel@medizin.uni-leipzig.de
G Pryymachuk
S Rath
O Bleiziffer
J P Beier
H Bruns
D Kluth
R Metzger
R E Horch
H Till
U Kneser
Leipzig University · DENational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of foetal liver cells (FLC) in the context of hepatic tissue engineering might permit efficient in vitro expansion and cryopreservation in a cell bank. A prerequisite for successful application of bioartificial liver tissue is sufficient initial vascularization. In this study, we evaluated the transplantation of fibrin gel-immobilized FLC in a vascularized arterio-veno-venous (AV)-loop model. FLC were isolated from embryonic/foetal (ED 16) rat livers and were enriched by using magnetic cell sorting (MACS). After cryopreservation, FLC were labelled by pkh-26. Cells were transplanted in a fibrin matrix into a subcutaneous chamber containing a microsurgically created AV-loop in the femoral region of the recipient rat. The chambers were explanted after 14 days. Subcutaneous implants without an AV-loop and cell-free implants served as controls. Fluorescence microscopy of the constructs was used to identify pkh-26(+)- donor cells. Characterization was performed by RT-PCR and immunhistology (IH) for CK-18 and CD31. Transplantation of FLC using the AV-loop permitted a neo-tissue formation in the fibrin matrix. A high-density vascularization was observed in the AV-loop constructs as shown by CD31 IH. Viable foetal donor cells were detected which expressed CK-18. FLC can be successfully used for heterotopic transplantation. Fibrin matrix permits rapid blood vessel ingrowth from the AV-loop and supports engraftment of FLC. It is therefore an appropriate environment for hepatocyte transplantation in combination with microsurgical vascularization strategies. Transplantation of fibrin gel-immobilized FLC may be a promising approach for the development of highly vascularized in vivo tissue-engineering-based liver support systems.

Indexed as

Cell Culture TechniquesAnimalsCell DifferentiationFemaleFetusFibrinHepatocytesHumansImmunomagnetic SeparationLiver, ArtificialPregnancyRatsRats, Inbred LewTissue EngineeringTissue ScaffoldsFibrin

Identifiers

PMID18505475
PMCPMC3837593
OpenAlexW2079587101

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.